Westell's ConferencePlus(R) Hosts Live Webcast "Social Media in Healthcare Marketing"

SCHAUMBURG, IL, May 17 (MARKET WIRE) --
Conference Plus, Inc. (ConferencePlus(R)), a subsidiary of Westell
Technologies, Inc. (NASDAQ: WSTL), and a leading provider of global
conferencing solutions, today announced a live webcast available to the
public. This webcast is part of ConferencePlus' monthly Ask the Expert
Webinar Series.

Scheduled for Thursday, May 19th, 2011 at 10:00 am (PDT)/12:00 noon
(CDT)/1:00 pm (EDT), "Social Media in Healthcare Marketing" is targeted
to healthcare and pharma marketers and is available to the public through
ConferencePlus' Event Services. The live webcast will address questions
from healthcare marketers on best practices for using social media while
avoiding warning letters from the FDA.

This informative event comes at a time when healthcare and pharmaceutical
marketers are awaiting FDA guidelines surrounding the use of digital
marketing in the healthcare industry. The FDA's twice-delayed
announcement of new guidelines for online and social media marketing
leaves healthcare marketing professionals with no defined clarity on
possible FDA constraints.

To address the current uncertainty in the industry, ConferencePlus will
host two expert speakers to cover best practices for healthcare
marketers. The main speaker, Tyler Pennock, Senior Vice President,
Digital Media, Cohn & Wolfe, specializes in creating online strategies
for healthcare clients that generate buzz and build relationships with
patients, professionals and advocates. Tyler is joined by guest speaker
and healthcare marketing leader Elizabeth Cermak, Executive Vice
President, Chief Commercial Officer, POZEN Inc. Ms. Cermak will share her
perspective on the evolution to "Pharma 3.0" and how her company is
developing a commercial model that leverages digital platforms to engage
key healthcare decision makers.

"While healthcare professionals await the FDA's new guidelines on digital
marketing, it is important for the industry to innovate new ways of using
web 2.0 technologies and social media to reach out to their audiences,"
said Dan Papa, Senior Vice President, Global Sales for ConferencePlus.
"As companies evolve their marketing programs in the digital arena, our
specialized Healthcare and Pharmaceutical Services team can help them
reach their audience. We understand the medical industry and specialize
in developing and delivering communication solutions to meet their
needs," Mr. Papa added.

Join ConferencePlus' Healthcare & Pharmaceutical Services team for this
live webcast on Thursday, May 19th, 2011, 10:00 am (PDT)/12:00 noon
(CDT)/1:00 pm (EDT), "Social Media in Healthcare Marketing".

Use the following link to register for this complimentary live webcast
event:
http://goo.gl/Y6mR2

About Conference Plus, Inc.
Conference Plus, Inc., a leading global
provider of audio, video, webcasting and web conferencing services, is
dedicated to providing high quality, reliable conferencing services that
customers trust with their most important events. ConferencePlus is
leading the way in providing innovative IP-based collaboration solutions
backed by proven technology and exceptional customer service.
Headquartered in Schaumburg, Illinois with an international headquarters
in Dublin, Ireland, ConferencePlus is a subsidiary of Westell
Technologies, Inc. (NASDAQ: WSTL). Additional information about
ConferencePlus can be obtained by visiting http://www.conferenceplus.com.

About Westell Technologies, Inc.
Westell Technologies, Inc.,
headquartered in Aurora, Illinois, is a holding company for Westell, Inc.
and Conference Plus, Inc. Westell, Inc. designs, distributes, markets and
services a broad range of broadband networking equipment, digital
transmission, remote monitoring, power distribution and demarcation
products used by telephone companies and other telecommunications service
providers. Additional information can be obtained by visiting
http://www.westell.com.

About POZEN
POZEN Inc. is a progressive pharmaceutical company that is
transforming how the healthcare industry addresses unmet medical needs.
By utilizing a unique in-source model and focusing on integrated
therapies, POZEN has successfully developed and obtained FDA approval of
two self-invented products in two years -- something almost no other
small pharmaceutical company has done. Funded by these two
milestone/royalty streams, POZEN is now creating a portfolio of
cost-effective, evidence based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI toxicity. The lead
candidate, PA32540, is being investigated for the secondary prevention of
cardiovascular disease in patients at risk for aspirin-induced ulcers and
has entered Phase 3 clinical trials. POZEN is retaining commercial
control of the pipeline assets and will develop a 21st century sales and
marketing organization using a new sales force model and digital
communications. The Company's common stock is traded on The NASDAQ Stock
Market under the symbol "POZN". For more detailed company information,
including copies of this and other press releases, please visit:
www.pozen.com.

For Additional Information Contact:

Brian Voss
Conference Plus, Inc.
1051 Woodfield Rd.
Schaumburg, IL 60173
Phone : 847/413-2790
Email : bvoss@conferenceplus.com
Web: www.conferenceplus.com

Copyright 2011, Market Wire, All rights reserved.

-0-